HeartBeam will not build large commercial organization for arrhythmia indication
Heartbeam Inc. will redirect the majority of its resources toward heart attack detection, and will not build a large commercial organization for arrhythmia indication.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
HeartBeam will not build a large commercial organization for arrhythmia indication
HeartBeam to prioritize heart attack detection, shares strategic focus
HeartBeam, Inc. has decided to prioritize heart attack (myocardial infarction) detection, redirecting the majority of its resources toward this opportunity. The company will continue limited commercialization of its existing arrhythmia product but will not build a large commercial organization around it. HeartBeam also